RXD ETF Research - ProShares UltraShort Health Care

ProShares UltraShort Health Care (rxd)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New ETF | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 115

Threats + Weaknesses = 70

When strengths & opportunities substantially exceed threats & weaknesses an investment in the rxd ETF has great long term potential.

ETF Description Update

ProShares UltraShort Health Care (RXD) Description: RXD is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. RXD exchange trading fund (ETF) tracks the U.S. Health Care (-200%); proshares ultrashort health care seeks daily investment results that correspond to twice (200%) the inverse (opposite) of the daily performance of the dow jones u.s. health care index ProShares UltraShort Health Care (RXD) falls under the Leveraged Equities category. RXD's dividend yield is roughly 0%, it has an expense ratio of 0.95%, and is in the equity ETF asset class. ProShares UltraShort Health Care (RXD) focuses its investments in the U.S. region of the world. RXD has an ETF leverage of two times (2x) and the performance of the RXD ETF is inversely-related to its benchmark; in other words, RXD is short the index. The RXD ETF belongs to the Health & Biotech sector. An investor can find RXD's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features RXD's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on ProShares ETF funds or see the ETF research & analysis home page to start.

Portfolio Strategy Update

Be the first to explain ProShares UltraShort Health Care (RXD)'s strategy.

Performance Analysis Update